From requirements to verified decisions
Identify the applicable requirement, select an authoritative domain reference, test for contradiction or omission, and record the approved disposition.
Nextvise’s 19-page white paper explains how regulated institutions move from applicable requirements to verified AI decisions: checking consequential outputs against controlled terminology and authoritative sources, then enforcing the approved response at runtime. Examples cover clinical assertions, pharmacovigilance, precision medicine and GxP manufacturing.
Download white paper (PDF)An approved system is not enough. The consequential output must also be supported, controlled and reconstructable.
The paper connects regulatory requirements to domain-grounded verification and a reproducible runtime disposition, supported by a reference matrix to primary regulatory and technical sources.
Identify the applicable requirement, select an authoritative domain reference, test for contradiction or omission, and record the approved disposition.
Examples cover clinical assertions, pharmacovigilance, precision medicine and pharmaceutical manufacturing, grounded in controlled terminology and sources.
Apply Approve, Escalate or Block conditions, route uncertain cases to qualified people, and preserve the source, control and accountable action.
Answers drawn from the paper’s operating model and reference matrix.
It is the gap between governing an AI system before deployment and verifying that each consequential output is supported by the domain facts and controls required for its intended use.
It links an applicable requirement to an authoritative domain reference, tests for contradiction, omission or unsupported claims, then applies an approved outcome: Approve, Escalate or Block.
No. The paper directs uncertain, conflicting or consequential cases to a qualified professional when judgment is needed. Deterministic controls make approved rules reproducible; they do not make medicine, law or science mechanically certain.
Examples include clinical assertions, pharmacovigilance, precision medicine and pharmaceutical manufacturing. Its reference matrix includes sources such as EMA GVP Module VI, MedDRA, RxNorm, ClinVar, FDA guidance, the EU AI Act, ISO/IEC 42001 and NIST AI RMF.
No. The paper describes its control reference matrix as a navigation aid, not legal advice. Applicability depends on role, jurisdiction, intended use and the specific decision.
Read the full public white paper, including the regulatory reference matrix. No registration required.